Pfizer has submitted a request for the Food and Drug Administration to provide emergency use authorization for its oral antiviral pill to help fight COVID-19 in high-risk adult patients. Dr. Payal Patel, an infectious disease physician at the University of Michigan, joins CBSN to with more on Pfizer's new pill and the pandemic.
